Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Safety and Pharmacokinetic Study of KB15A Vaginal Film
NCT07222020Phase 1Recruiting
- Sponsor
- ZabBio
- Start
- Dec 2025
- Primary completion
- Mar 2027
- Modality
- Transdermal Patches, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in pregnancy comparing KB15A with Placebo (2 arms). Primary endpoints: Treatment Emergent Adverse Events, Change in colposcopic findings and 1 more. Started Dec 2025; status: recruiting.
02
Drugs
ZB-06
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT07222020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07222020.